Importantly, analysis of the TCGA database showed a statistically significant positive correlation between ATXN3 and PD-L1 expression in the majority of types of human cancers, implying that ATXN3 is a positive regulator of PD-L1 in a broad spectrum of human cancers. This evidence concerns the gene CD274 and cancer.